The impact of CYP2C19 and CYP4F2 variants and clinical factors on treatment outcomes during antiplatelet therapy
Tatarunas, Vacis, Kupstyte-Kristapone, Nora, Norvilaite, Rita, Tamakauskas, Vytenis, Skipskis, Vilius, Audrone, Veikutiene, Jurgaityte, Julija, Stuoka, Mantvydas, Lesauskaite, VaivaVolume:
20
Language:
english
Journal:
Pharmacogenomics
DOI:
10.2217/pgs-2018-0178
Date:
May, 2019
File:
PDF, 454 KB
english, 2019